Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial

OBJECTIVES: The hypothesis of the study is that treatment with hydroxychloroquine sulphate in hospitalised patients with coronavirus disease 2019 (Covid-19) is safe and will accelerate the virological clearance rate for patients with moderately severe acute respiratory syndrome coronavirus 2 (SARS-C...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Trials
Autors principals: Lyngbakken, Magnus Nakrem, Berdal, Jan-Erik, Eskesen, Arne, Kvale, Dag, Olsen, Inge Christoffer, Rangberg, Anbjørg, Jonassen, Christine Monceyron, Omland, Torbjørn, Røsjø, Helge, Dalgard, Olav
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Letter
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7273378/
https://ncbi.nlm.nih.gov/pubmed/32503662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04420-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars